Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion deal, accelerating efforts to broaden its respiratory portfolio as it prepares for the loss of exclusivity on its blockbuster cancer drug Keytruda later this decade.Cidara’s shares more than doubled in premarket trading on Friday, jumping…
Applied Materials’ shares fell sharply in premarket trading on Friday, dropping more than 7%, after the chip equipment maker…
Investors are pushing Argentina to relax its foreign-exchange regime, contending that a more flexible peso would be a big help…
Gold prices slumped more than 3% on Friday as a December interest rate cut by the US Federal Reserve…
After months of punishing trade tensions, the US and Switzerland announced a breakthrough deal on Friday that will slash…
Europe saw a flurry of political and economic developments this week, from a major US–Swiss trade breakthrough to the…
The copper rally fizzled out quickly after the metal briefly soared past $11,000 per ton, as disappointing economic figures…
President Donald Trump is preparing an executive order that will reduce tariffs on several widely consumed food imports, including…
In a fast-moving Friday across Washington and Wall Street, the United States announced a major breakthrough trade deal with…